A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder
Clinical trial NCT07285798 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07285798
- Sponsor
- Bristol-Myers Squibb
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-09-11
- Primary completion
- 2029-08-04
- Enrollment
- 176
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.